53 results
6-K
EX-10.5
QNRX
Quoin Pharmaceuticals Ltd
29 Oct 21
Report of Foreign Private Issuer
9:31am
Exhibit 10.5
Adopted by the Board of Directors: October 28, 2021
CHARTER OF THE
NOMINATING AND GOVERNANCE COMMITTEE
OF THE BOARD OF DIRECTORS …
OF
QUOIN PHARMACEUTICALS, LTD.
Purpose
The Nominating and Governance Committee (the “Committee”) shall report to and assist the Board of Directors
6-K
EX-10.2
QNRX
Quoin Pharmaceuticals Ltd
8 Mar 22
Notice of Annual General Meeting of Shareholders
5:20pm
Exhibit 10.2
QUOIN PHARMACEUTICALS LTD.
AMENDED AND RESTATED CHARTER OF
THE NOMINATING AND GOVERNANCE COMMITTEE OF
THE BOARD OF DIRECTORS … indicates otherwise.
Purpose
The Nominating and Governance Committee (the “Committee”) shall report to and assist the Board of Directors (the “Board
6-K
EX-10.3
QNRX
Quoin Pharmaceuticals Ltd
8 Mar 22
Notice of Annual General Meeting of Shareholders
5:20pm
for a deviation from the Compensation Policy.
The Company has adopted the corporate governance structure set forth in Regulation 5D of the Israeli … . In accordance with such corporate governance structure as set forth in Regulation 5D of the Relief Regulations, for so long as the Company does
6-K
QNRX
Quoin Pharmaceuticals Ltd
8 Mar 22
Notice of Annual General Meeting of Shareholders
5:20pm
herein by reference, (iii) the Board’s nominating and governance committee was comprised of Natalie Leong (chair) and Joseph Cooper, (iv) the charter … of the Nominating and Governance Committee of the Board was amended and restated, in the form attached hereto as Exhibit 10.2 and incorporated herein
6-K
EX-10.1
QNRX
Quoin Pharmaceuticals Ltd
8 Mar 22
Notice of Annual General Meeting of Shareholders
5:20pm
governance structure set forth in Regulation 5D of the Israeli Companies Regulations (Relief for Public Companies with Shares Listed for Trading on a Stock … of the opposite gender shall be elected or appointed. In accordance with such corporate governance structure as set forth in Regulation 5D
PRE 14A
7ipswx
1 Sep 23
Preliminary proxy
1:38pm
DEF 14A
ac0ik0gfe ve
12 Sep 23
Definitive proxy
6:03am
6-K
z8rxjfiw227iccr0a9x
29 Oct 21
Report of Foreign Private Issuer
9:31am
424B3
2arbwg3ucb6
25 Apr 22
Prospectus supplement
6:40pm
F-1
7r8g alzc
15 Apr 22
Registration statement (foreign)
12:00am
6-K
puu foeff
11 Aug 22
Quoin Pharmaceuticals Announces Pricing of $16.8 Million Upsized Public Offering
9:10am
20-F
t8tsfo8naijqrz
23 Mar 17
Annual report (foreign)
12:00am
424B4
6sqqxoh map6
8 Aug 22
Prospectus supplement with pricing info
5:49pm
6-K
EX-99.1
qivvtryxd p3
24 Jan 19
Report of Foreign Private Issuer
5:05pm
F-1/A
57wceye
4 Aug 22
Registration statement (foreign) (amended)
11:44am
F-1
ghdwrtn
2 Aug 22
Registration statement (foreign)
9:49pm